A top Democrat on the House antitrust panel sets sights on Big Pharma after wrapping up tech probe

by Raphael Stevens 24 November 2020, 11:05 189 Views

Rep. Joe Neguse, D-Colo., wants the committee to examine the FTC’s common approach to approving pharmaceutical mergers.

Why Bitcoin price just hit $19,000 for the first time in 3 years

3 reasons Ethereum's momentum is only accelerating as ETH nears $600

This portal is not a newspaper as it is updated without periodicity. It cannot be considered an editorial product pursuant to law n. 62 of 7.03.2001. The author of the portal is not responsible for the content of comments to posts, the content of the linked sites. Some texts or images included in this portal are taken from the internet and, therefore, considered to be in the public domain; if their publication is violated, the copyright will be promptly communicated via e-mail. They will be immediately removed.

A top Democrat on the House antitrust panel sets sights on Big Pharma after wrapping up tech probe

Why Bitcoin price just hit $19,000 for the first time in 3 years

3 reasons Ethereum's momentum is only accelerating as ETH nears $600

ITALIAN LANGUAGE

ENGLISH LANGUAGE